Clinical Trial Update: A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients [Phase 2]

View source ↗

Summary

A Phase II randomized, double-blind trial comparing 566C80 to Septra (sulfamethoxazole/trimethoprim) for Pneumocystis pneumonia in HIV/AIDS patients has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumocystis Pneumonia

Drugs mentioned

• 566C80
• Septra (sulfamethoxazole/trimethoprim)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 2 | Status: COMPLETED